Residency · Residency · Emergency Medicine
Ectopic Pregnancy: Diagnosis and Time-Critical Management
Introduction
Ectopic pregnancy occurs when a fertilized ovum implants outside the endometrial cavity, most commonly in the fallopian tube. It remains a leading cause of maternal mortality in the first trimester, accounting for approximately 2.7 percent of pregnancy-related deaths in the United States. The emergency physician must maintain a high index of suspicion in any reproductive-age female presenting with abdominal pain or vaginal bleeding, as ruptured ectopic pregnancy is a surgical emergency requiring immediate intervention.
Epidemiology and Risk Factors
Ectopic pregnancy occurs in approximately 1 to 2 percent of all pregnancies, and the incidence has increased with rising rates of PID, assisted reproductive technology, and improved diagnostic detection. Risk factors, in order of significance, include prior ectopic pregnancy (which carries a 10 to 25 percent recurrence risk), prior tubal surgery or tubal ligation (with a failure rate of 0.5 to 1 percent), history of pelvic inflammatory disease or salpingitis, in utero DES exposure, and current intrauterine device use. An IUD does not increase ectopic risk overall, but if pregnancy occurs with an IUD in situ, a higher proportion of those pregnancies are ectopic. Assisted reproductive technology, particularly IVF, increases the heterotopic pregnancy risk to 1 in 100. Smoking has a dose-dependent effect by impairing tubal motility, and endometriosis is an additional risk factor. Critically, 50 percent of women with ectopic pregnancy have no identifiable risk factors.
Anatomy of Implantation Sites
The ampullary segment accounts for 70 percent of ectopic pregnancies and is the most common location; it may resolve spontaneously or rupture. The isthmic segment accounts for 12 percent and, being a narrow segment, tends to rupture earlier due to limited distensibility. The fimbrial segment accounts for 11 percent and may result in tubal abortion. The interstitial or cornual segment accounts for 2 to 3 percent and is the most dangerous location, rupturing later at 8 to 16 weeks with massive hemorrhage due to proximity to the uterine artery, carrying a mortality rate up to 2 percent. Rare non-tubal ectopic sites include ovarian, cervical, abdominal, and cesarean scar implantation.
Clinical Presentation
The classic triad of abdominal or pelvic pain, vaginal bleeding, and amenorrhea is present in only 50 percent of cases. Pain is typically unilateral, sharp, and may radiate to the shoulder from diaphragmatic irritation by hemoperitoneum, known as the Kehr sign. Vaginal bleeding is typically light and irregular and may be mistaken for menses. Ruptured ectopic presents with sudden severe abdominal pain, signs of hemorrhagic shock (tachycardia, hypotension, pallor), peritoneal signs, and syncope. Atypical presentations include isolated shoulder pain, diarrhea, urinary symptoms, and vaginal bleeding without pain.
<image>Anatomical illustration of the female reproductive tract showing the different implantation sites for ectopic pregnancy with percentage frequency: ampullary (70%), isthmic (12%), fimbrial (11%), interstitial/cornual (2-3%), ovarian (1%), cervical (<1%), and abdominal (<1%), with color-coding to indicate relative rupture risk at each site</image>
Diagnostic Approach
Pregnancy Test
A qualitative urine hCG serves as the initial screening test, with sensitivity approaching 99 percent for pregnancy detection. Quantitative serum beta-hCG is essential for management decisions and correlation with ultrasound findings. The discriminatory zone is the beta-hCG level above which an intrauterine pregnancy should be visualized on ultrasound. For transvaginal ultrasound, this threshold is 1,500 to 3,000 mIU/mL (institution-dependent). If the beta-hCG is above the discriminatory zone and no intrauterine pregnancy is visualized, ectopic pregnancy must be strongly suspected.
Transvaginal Ultrasound
Transvaginal ultrasound is the first-line imaging modality for all hemodynamically stable patients with suspected ectopic pregnancy. Findings suggestive of intrauterine pregnancy include a gestational sac with yolk sac or fetal pole within the endometrium, which rules out ectopic in most cases but does not rule out heterotopic pregnancy. Findings suggestive of ectopic include an extrauterine gestational sac, an adnexal mass separate from the ovary, the ring of fire sign (peripheral hypervascularity on Doppler), and free fluid in the cul-de-sac. An empty uterus with a beta-hCG above the discriminatory zone is an ectopic pregnancy until proven otherwise. A pregnancy of unknown location describes the situation where the beta-hCG is below the discriminatory zone with no intrauterine pregnancy or ectopic visualized, requiring serial monitoring.
Point-of-Care Ultrasound
Emergency physicians can rapidly identify an intrauterine pregnancy with point-of-care ultrasound, achieving a sensitivity of 90 to 100 percent for detecting IUP. The presence of an intrauterine pregnancy on POCUS effectively rules out ectopic pregnancy, as the heterotopic pregnancy risk is 1 in 30,000 in natural conception. Free fluid in Morrison's pouch in a pregnant patient with pain or hemodynamic instability is highly concerning for ruptured ectopic with hemoperitoneum.
Serial Beta-hCG Monitoring
In a viable early intrauterine pregnancy, beta-hCG should rise by at least 35 percent in 48 hours (previously quoted as doubling, but the 35 percent minimum rise is more sensitive). An inappropriately rising, falling, or plateauing beta-hCG suggests either ectopic pregnancy or nonviable intrauterine pregnancy. Declining beta-hCG does not exclude ectopic, as tubal rupture can occur even with falling levels.
Management
Hemodynamically Unstable -- Ruptured Ectopic
A ruptured ectopic pregnancy is a surgical emergency. The massive transfusion protocol should be activated, and volume resuscitation with crystalloid and blood products should begin immediately. Emergent operative intervention, typically laparoscopic salpingectomy (or laparotomy if the patient is in extremis), should not be delayed for ultrasound confirmation if the clinical presentation is consistent with ruptured ectopic and the patient is unstable.
Hemodynamically Stable -- Medical Management
Methotrexate is the first-line medical therapy for unruptured ectopic pregnancy in appropriate candidates. Eligibility criteria include hemodynamic stability, an unruptured ectopic, beta-hCG below 5,000 mIU/mL (optimal), adnexal mass less than 3.5 cm, no fetal cardiac activity, reliability for follow-up, and no contraindications to methotrexate. The single-dose protocol is methotrexate 50 mg/m2 IM, with beta-hCG rechecked on day 4 and day 7 expecting at least a 15 percent decline between those days, and a repeat dose given if criteria are not met. The multi-dose protocol is methotrexate 1 mg/kg IM on days 1, 3, 5, and 7 alternating with leucovorin 0.1 mg/kg on days 2, 4, 6, and 8, and carries a higher success rate for beta-hCG levels above 5,000. Pre-treatment labs include CBC, BMP (creatinine), liver function tests, type and screen, and beta-hCG. Contraindications to methotrexate include immunodeficiency, hepatic disease, renal insufficiency, blood dyscrasias, active pulmonary disease, breastfeeding, and ruptured ectopic. The success rate is 82 to 94 percent for appropriately selected patients.
Hemodynamically Stable -- Surgical Management
Surgical management is indicated when methotrexate is contraindicated, the beta-hCG exceeds 5,000, fetal cardiac activity is present, the patient prefers surgical management, or medical management fails. Laparoscopic salpingectomy is the standard of care for most cases and is preferred over salpingostomy unless the contralateral tube is absent or damaged. Salpingostomy, which involves a linear incision to remove ectopic tissue while preserving the tube, carries a higher risk of persistent trophoblastic tissue.
<image>Transvaginal ultrasound image showing an ectopic pregnancy in the right adnexa with a visible extrauterine gestational sac containing a yolk sac, an empty uterus with thickened endometrium (pseudogestational sac), and a small amount of free fluid in the cul-de-sac, with labeled annotations</image>
Special Scenarios
Heterotopic pregnancy, the coexistence of an intrauterine pregnancy and an ectopic, occurs in 1 in 30,000 natural conceptions but up to 1 in 100 with assisted reproductive technology. Methotrexate is contraindicated because it would harm the intrauterine pregnancy, and surgical management is required. Interstitial ectopic ruptures later with higher morbidity, may require cornual resection, and has a lower methotrexate success rate. Cervical ectopic can cause heavy vaginal bleeding upon manipulation and may require uterine artery embolization. Cesarean scar ectopic is increasing in incidence and carries a high risk of uterine rupture and catastrophic hemorrhage.
Clinical Pearls
All reproductive-age females with abdominal pain, vaginal bleeding, or syncope should have a pregnancy test as part of the initial workup. An empty uterus on transvaginal ultrasound with a beta-hCG above the discriminatory zone is ectopic until proven otherwise. Hemodynamically unstable patients with suspected ruptured ectopic require emergent surgery, and imaging should not delay operative intervention. Methotrexate is highly effective for appropriately selected patients but requires reliable follow-up for serial beta-hCG monitoring. Up to 50 percent of women with ectopic pregnancy have no identifiable risk factors, so clinical suspicion must remain high.
References
- Barnhart KT. Ectopic pregnancy. N Engl J Med. 2009;361(4):379-387.
- ACOG Practice Bulletin No. 193: Tubal ectopic pregnancy. Obstet Gynecol. 2018;131(3):e91-e103.
- Seeber BE, Barnhart KT. Suspected ectopic pregnancy. Obstet Gynecol. 2006;107(2 Pt 1):399-413.
- Hendriks E, Rosenberg R, Prine L. Ectopic pregnancy: diagnosis and management. Am Fam Physician. 2020;101(10):599-606.
